Monday Night Discussion Group
Join the Conversation:
Free, Live, Weekly, Clinician Education
Join our free LIVE, weekly, virtual Monday Night Discussion Group (MNDG) held on Mondays from 8:00-9:00 pm EST.
Each week, Dr. Lisa Larkin hosts a free, live educational discussion with a nationally recognized women’s health expert. These interactive sessions are designed for open, collegial dialogue around timely, complex, and evolving topics in women’s health.
Free registration includes access to the live session. All clinicians are welcome.
2026 MNDG Schedule
2026 Women's Health Update
The 2026 Women's Health Update is a comprehensive one-day CME covering MHT prescribing, GLP-1 therapies and cardiometabolic risk, CVD risk assessment, and breast cancer screening — with interactive cases and a networking reception. June 19, 2026 at The Summit Hotel, Cincinnati. Limited seating.
MCED Testing Beyond Galleri: Cancerguard and Shield MCD - Candace Westgate, DO, MPH, FACOG, MSCP
Candace Westgate, DO, MPH, FACOG, MSCP, Director of Personalized Medicine at Community Health Network, compares CancerGuard and Shield MCD — technologies, validation data, and counseling frameworks — for clinicians navigating MCED conversations. Free live MNDG, June 22 at 8 PM ET.
Breast Cancer Genetics and Cancer Risk Reduction - Allison W. Kurian, MD, MSc
Allison Kurian, MD, MSc, Director of Stanford's Women's Clinical Cancer Genetics Program, reviews multigene panel testing, the evolving evidence on moderate-risk genes, and how to translate genetic results into clinical action for breast cancer risk. Free live MNDG, June 29 at 8 PM ET.
The Great Menopause Debate - The NEW ACOG Guidelines: Evaluation of Postmenopausal Bleeding - Steven R. Goldstein, MD, CCD, MSCP, FACOG
Steven Goldstein, MD, CCD, MSCP, FACOG — developer of saline infusion sonohysterography and a leading voice in menopausal ultrasound — critically examines the new ACOG postmenopausal bleeding guidelines: what the evidence supports, and what it doesn't. Free live MNDG, July 13 at 8 PM ET.
Update on DCIS - Laura J. Esserman, MD, MBA
Ductal carcinoma in situ is evolving rapidly — and so is the evidence guiding its management. In this CME session, Dr. Laura Esserman provides a current, evidence-based review of DCIS diagnosis, risk stratification, and treatment, including emerging data on active surveillance and the growing movement away from overtreatment.
Work up on Abnormal Uterine Bleeding in the Perimenopause/Menopause - Steven R. Goldstein, MD, CCD, MSCP, FACOG
Steven Goldstein, MD, CCD, MSCP, FACOG offers a systematic, evidence-based framework for evaluating abnormal uterine bleeding in perimenopausal and menopausal women — covering imaging, endometrial sampling, and the clinical decision points that guide management. Free live MNDG, July 27 at 8 PM ET.
Pain with Sex - Jen Gunter, MD, FRCS(C), FACOG, DABPM, ABPMR
Pain with sex affects a significant proportion of midlife women — and most providers don't have a systematic framework for addressing it. Dr. Jen Gunter, one of women's health's most recognized and evidence-driven voices, reviews the full clinical picture: how to differentiate GSM from vulvodynia from pelvic floor dysfunction, what the evidence supports for treatment, and how to have the clinical conversations that move patients toward relief.
As the Menoverse Expands: When Does Perimenopause Begin and How Can We Help? - Marcie Richardson, MD, FACOG
Marcie Richardson, MD, FACOG reviews the science of perimenopause onset — including the Late Reproductive Stage — and offers practical strategies for identifying and supporting women earlier in the hormonal transition. Free live MNDG, Aug 10 at 8 PM ET.
Type 2 Diabetes Management: Medications Other Than GLP’1s - Jyothi Joseph-Hayes, MD
Jyothi Joseph-Hayes, MD provides a practical, evidence-based review of Type 2 diabetes pharmacotherapy beyond GLP-1 receptor agonists — covering the full range of medication classes and considerations for individualized treatment decisions. Free live MNDG, Aug 24 at 8 PM ET.
Alzheimer’s Genetics Reinterpreted, Alzheimer’s Disease Redefined - Alberto Espay, MD, MSc, FAAN, FANA
Alberto Espay, MD, MSc, FAAN, FANA, Professor at the University of Cincinnati, examines emerging genetic insights redefining Alzheimer's disease — including evolving risk models, diagnostic implications, and therapeutic approaches. Free live MNDG, Aug 31 at 8 PM ET.
Update on WISDOM - Allison Stover Fiscalini, MPH
Allison Stover Fiscalini, MPH, presents the latest WISDOM study findings — comparing personalized, risk-based breast cancer screening to annual mammography — and what the Phase 1 data means for clinical screening guidelines and shared decision-making. Free live MNDG, Sept 14 at 8 PM ET.
Adolescent Gynecology - Leslie Appiah, MD
Leslie Appiah, MD, a nationally recognized leader in reproductive health equity, delivers a focused, practical session on adolescent gynecology for non-specialist providers — covering common presentations, referral criteria, and affirming, equity-centered approaches to care. Free live MNDG, Sept 28 at 8 PM ET.
Migraine During Perimenopause - Katherine T. Hamilton, MD
Katherine Hamilton, MD, headache specialist at MedStar Georgetown's Headache Center, delivers a clinical framework for migraine during perimenopause — covering acute and preventive treatment evidence and practical considerations around hormone therapy in this population. Free live MNDG, Oct 5 at 8 PM ET.
Complex Menopause Cases - Risa Kagan, MD, FACOG, CCD, MSCP
Risa Kagan, MD, FACOG, CCD, MSCP — one of the country's leading menopause specialists — uses a case-based format to work through complex clinical scenarios that go beyond standard guidelines, sharpening decision-making for patients who don't fit the algorithm. Free live MNDG, Oct 12 at 8 PM ET.
Orgasm - Lauren Streicher, MD, FACOG, MSCP
Lauren Streicher, MD, FACOG, MSCP, founder of Northwestern's Center for Menopause and Sexual Health, reviews orgasmic dysfunction across the menopausal transition — mechanisms, hormonal contributors, and both pharmacologic and non-pharmacologic treatment options. Free live MNDG, Oct 26 at 8 PM ET.
Precision Breast Health - Radiomics and AI in Breast Imaging - Connie Lehman, MD, PhD
Connie Lehman, MD, PhD, brings the science of AI and radiomics in breast imaging to MNDG — exploring how these tools are reshaping risk stratification, screening precision, and clinical decision-making in breast health. Free live MNDG, Nov 2 at 8 PM ET.
The Great Menopause Debate - Should MHT be Prescribed for Brain Health — Including Mood, Sleep, and Dementia Prevention? - Panel Discussion
The biology is compelling. The observational data is suggestive. The randomized trial evidence is mixed. And the patients are asking. In this Great Debates in Menopause session, HERmedicine convenes expert panelists to argue the evidence for and against MHT as a brain health intervention — covering mood, sleep, cognitive function, and dementia prevention with the rigor and candor the question demands.
Breast Health and MHT: How to Counsel Women at Elevated Risk - Sabrina Sahni, MD, MSCP
Sabrina Sahni, MD, MSCP, with dual expertise in specialized women's health and medical breast medicine, delivers a structured framework for MHT counseling spanning benign breast disease, dense breasts, BRCA carriers, and cancer survivors. Free live MNDG, Nov 16 at 8 PM ET.
The Midlife Women’s Health Update - Evidence Based Menopause Care in the Era of Longevity Medicine
The 2026 Midlife Women's Health Summit is a three-day menopause CME co-chaired by Larkin, Gunter, and Streicher — covering menopause management, hormonal health, sexual medicine, and longevity medicine through case-based sessions. 18 AMA PRA Category 1 Credit(s)™. Nov 20–22, The Ritz-Carlton, Pentagon City, VA.
The Rationale For Checking Estradiol Levels - James A. Simon, MD, CCD, MSCP, IF, FACOG & Sarah Glynne, MBBS, MSc, MRCP, MRCGP
James Simon, MD, MSCP, IF and Sarah Glynne, MBBS, MSc, MRCP, MRCGP, bring complementary US and UK clinical perspectives to estradiol monitoring in MHT — presenting a structured case for monitoring as a tool to optimize dosing, address persistent symptoms, and manage safety in complex patients. Free live MNDG, Nov 30 at 8 PM ET.
Nutrition Guidelines and Fitness for Health: What you Should Know in The Era of Social Media and the New Guidelines - Karl Nadolsky, DO, FACE, DABOM & Spencer Nadolsky, DO, DABOM
Karl and Spencer Nadolsky, DO — endocrinologists with combined expertise in obesity medicine and evidence-based health communication — review the new nutrition and physical activity guidelines and how to counsel patients who walk in with strong, algorithm-driven opinions. Free live MNDG, Dec 7 at 8 PM ET.
Hereditary Cancer Risk Management - Michelle Jacobson, MD, FRCSC
Michelle Jacobson, MD, FRCSC, a lead author of national hereditary cancer and menopause management guidelines, delivers a focused clinical review of BRCA counseling, risk-reducing surgery, surveillance protocols, and menopause care for high-risk patients. Free live MNDG, Dec 14 at 8 PM ET.
Thyroid Update: Post Partum Thyroditis, Hashimotos, Graves - Abid Yaqub, MD, FACP, FACE, FCPS
Abid Yaqub, MD, FACP, FACE, FCPS, thyroid specialist at the University of Cincinnati, reviews postpartum thyroiditis, Hashimoto's, and Graves' disease — overlapping presentations, diagnostic workup, and the management decisions that matter most for women's health providers. Free live MNDG, Dec 21 at 8 PM ET.
Update on Treatment of FSD - Sharon Parish, MD & Sheryl Kingsberg, PhD
Sharon Parish, MD and Sheryl Kingsberg, PhD — two nationally recognized experts in female sexual medicine — deliver a focused update on FSD at midlife, covering testosterone, hormone therapy, HSDD pharmacology, and GSM treatment. Free live MNDG, June 15 at 8 PM ET.
Update on NKT's for VMS - Jill Liss, MD, MSCP, FACOG
Jill Liss, MD, MSCP, FACOG, Associate Clinical Professor at the University of Colorado, reviews NK3 receptor antagonists for vasomotor symptoms — mechanism, fezolinetant and elinzanetant trial outcomes, and patient selection criteria. Free live MNDG, June 8 at 8 PM ET.
Metabolic Disease in Midlife - Susan Brian, MD
Susan Brian, MD, endocrinologist at the Cotton-O'Neil Clinical Research Center, reviews diabetes, insulin resistance, and cardiometabolic risk as they evolve in midlife women. The June 1 MNDG covers risk stratification and evidence-based management.
Memorial Day - No MNDG
In honor of Memorial Day, HERmedicine's Monday Night Discussion will not meet on May 26th. We'll be back the following week with more women's health education. Wishing our community a meaningful and restful holiday.
Microbiome and Menopause: What is the Evidence - Dragana Skokovic-Sunjic, RPh, BScPhm, MSCP
The gut microbiome plays a surprising and significant role in women's hormonal health — and its connection to menopause is an area of rapidly growing research. In this HERtalks event, pharmacist and microbiome specialist Dragana Skokovic-Sunjic breaks down what the current evidence tells us and what it means for women navigating the menopausal transition.
Special Topics and What’s New in Contraception - James A. Simon, MD, CCD, MSCP, IF, FACOG
The contraception landscape has more options than ever — and the evidence guiding their use continues to evolve. Dr. James Simon, reproductive endocrinologist and one of women's health's most prolific clinical researchers, brings his signature depth and clinical precision to an up-to-date review of new contraceptive methods, safety considerations, and patient selection for clinicians who counsel and prescribe across the reproductive lifespan.
Who Owns Menopause Care? Business Models, Clinical Scope, and Standard of Care - Lisa Chacko, MD, MP, MSCP
Dr. Lisa Chacko, founder of Curate Medical and architect of the "menopause-informed care" framework, examines the forces reshaping menopause care delivery — and what clinicians need to know to stay ahead of them.
Integrating Botanicals into Midlife: What is the Evidence? - Suzanne Gilberg-Lenz, MD, FACOG
Dr. Suzanne Gilberg-Lenz examines what we actually know about commonly used botanical therapies at midlife — efficacy, safety, drug-herb interactions, and how to translate evolving evidence into grounded, patient-centered care.
The Pelvic Pain Pentad: Endometriosis · MCAS · POTS · hEDS · Pelvic Venous Disease - Jennifer Lanoff, WHNP-BC, MSCP, JD
Jennifer Lanoff, WHNP-BC, MSCP, presents a clinician framework for identifying the Pelvic Pain Pentad — endometriosis, MCAS, POTS, hEDS, and pelvic venous disease — and the overlapping presentations that make this constellation so frequently missed.
Update on GLP1's- Injectable, Oral, and Pipeline - Angela Fitch, MD, FACP, FOMA
This clinician education session with Angela Fitch, MD, FACP, FOMA, provides an up-to-date review of GLP-1–based therapies, including injectable and oral options and agents in the development pipeline. The discussion covers mechanisms of action, efficacy and safety data, clinical indications, and practical considerations for prescribing and patient counseling.
Mammography for Breast Cancer Screening- Where we are in 2026 - Anjali Malik, MD
This clinician education session with Anjali Malik, MD, reviews the current state of mammography for breast cancer screening in 2026. The discussion addresses evolving screening guidelines, advances in imaging technology, breast density considerations, and ongoing areas of clinical debate to support evidence-based screening and patient counseling.
Ovarian Cancer Screening - Mitchell Clark, MD, MPH
This clinician education session with Mitchell Clark, MD, MPH, examines the current evidence surrounding ovarian cancer screening. The discussion reviews population-level data, screening limitations, risk stratification, and guideline recommendations, with a focus on applying evidence to patient counseling and shared decision-making in clinical practice.
Progestin 2.0 - Tami S. Rowen, MD, MS
Not all progestins are created equal — and the differences matter for your patients. Dr. Tami Rowen brings her expertise in sexual medicine, menopause, and complex gynecologic care to break down the evolving progestogen landscape and its implications for your prescribing practice.
Anabolics - How and When to Prescribe - Andrea Singer, MD, FACP, CCD
This clinician education session with Dr. Andrea Singer examines the role of anabolic therapy in osteoporosis management. The discussion addresses patient selection, treatment timing and sequencing, duration of therapy, and safety considerations to support informed, evidence-based fracture prevention strategies.
Progestins - Marla Shapiro, CM, MDCM, CCFP, MHSc, FRCPC, FCFP
Dr. Marla Shapiro breaks down the latest evidence on progestins—helping clinicians choose the right option for hormone therapy, endometrial protection, and patient-specific needs.
SERMs: Menopause and Healthy Aging - Steven R. Goldstein, MD
Dr. Steven Goldstein reviews the role of SERMs in menopause and aging, highlighting how they can support symptom relief, bone health, and risk reduction in the right patients.
Presidents’ Day - No providHERS Discussion Group
In observance of President’s Day there is no providHERS Discussion Group
Update on Parkinson’s: What Women’s Health Clinicians Need to Know - Luca Marsili, MD, PhD
Dr. Luca Marsili shares the latest clinical and research updates in Parkinson’s disease, covering new approaches to diagnosis, symptom management, and treatment innovation.
Perimenopause 101 and AI for Positive Health Education: Meet Maya - Sophia Yen, MD, MPH, MSCP
This educational session reviews the clinical fundamentals of perimenopause and examines the role of AI-driven tools in delivering accurate, evidence-based health education. Dr. Sophia Yen introduces Maya, an AI platform designed to support patient understanding, improve engagement, and complement clinical care in hormonal and reproductive health.
CV Risk Assessment in Mid-Life Women and what to do with Lp(a). - Caitlin Giesler, MD
Dr. Caitlin Giesler explores when and how to use advanced lipid testing to improve risk assessment and prevention strategies, especially in midlife women with nuanced cardiovascular profiles.
Interprofessional Cases in Intersex and Transgender Sexual Health - Sarah Pickle, MD, Shanna Stryker, MD, MPH & Sarah Whitton, PhD
This interprofessional session explores real-world cases in intersex and transgender sexual health, highlighting collaborative, affirming approaches to care for sexual and gender minority patients.
The Winding Road of MHT: Evidence, Messaging & How to Counsel Patients Based on Risk in the Post November 10 and Label Change World - Lisa Larkin, MD, FACP, MSCP, IF
Join Dr. Lisa Larkin for an in-depth discussion on menopausal hormone therapy, exploring the evolving evidence, breast cancer risk data, and the impact of recent FDA labeling changes. This clinical session examines MHT history, current research, and practical, risk-based counseling strategies for patient care.
Pelvic Pain in Women: Diagnosis, Mechanisms, and Management Strategies - Neeraj Kohli, MD, MBA
Dr. Neeraj Kohli offers expert insight into the diagnosis and management of chronic pelvic pain, helping clinicians navigate this complex and multifactorial condition in women.
Vulvar Disorders: What Every Clinician Should Know - Andrew T. Goldstein, MD, FACOG
Dr. Andrew Goldstein offers expert guidance on diagnosing and managing vulvar disorders—equipping clinicians with tools to better care for patients with chronic vulvar pain and skin conditions.
Headaches and Hormones: Understanding the Link in Women’s Health - Pelin Batur, MD, FACP, MSCP
Dr. Pelin Batur explores the hormonal drivers of headaches in women and offers clinicians targeted strategies for diagnosis and treatment across the reproductive lifespan.
HERmedicine Expert Panel Discussion - Deep Dive - FDA Announcement: Removal of the Boxed Warning on Menopause Hormone Therapy
HERmedicine hosts a live expert panel exploring the FDA’s removal of the boxed warning on menopause hormone therapy. Hear leading clinicians and researchers discuss the science behind this decision, its impact on patient care, and what it means for the future of women’s midlife health.
Breast Imaging for Non-Radiologists - What You Need to Know. - Stacy Smith-Foley, MD
Dr. Stacy Smith-Foley equips non-radiologists with the knowledge to confidently order, interpret, and act on breast imaging results in everyday clinical practice.
A Menopause Practitioner’s Guide to Treating Low Libido - Alyse Kelly-Jones, MD, FACOG, IF
Dr. Alyse Kelly-Jones offers an expert guide for menopause practitioners treating low libido, covering hormones, communication, and personalized approaches to sexual well-being.
Evidence-Based Obesity Management in the ERA of GLP1's - Compounding & Cost/Insurance Issues - Courtney Younglove, MD, FOMA, FACOG, DABOM
Dr. Courtney Younglove explores how to deliver effective, evidence-based obesity care in the age of GLP-1s—balancing science, safety, cost, and access.
Past Monday Night Discussions
Explore a selection of past speakers who have helped shape the conversations in Monday Night Discussions, bringing expertise, insight, and diverse perspectives to each session.